Research programme: non-opioid analgesics - Sea4Us
Latest Information Update: 24 Jul 2023
At a glance
- Originator Sea4Us
- Class Non-opioid analgesics; Small molecules
- Mechanism of Action Kv1.3 potassium channel inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Neuropathic pain
Highest Development Phases
- Preclinical Neuropathic pain
- Research Autoimmune disorders; Cancer pain; Infections; Inflammatory pain; Overactive bladder
Most Recent Events
- 24 Jul 2023 Early research in Autoimmune disorders in Portugal (unspecified route) (Sea4Us pipeline, July 2023)
- 24 Jul 2023 Early research in Infections in Portugal (unspecified route) (Sea4Us pipeline, July 2023)
- 24 Jul 2023 Early research in Overactive bladder in Portugal (unspecified route) (Sea4Us pipeline, July 2023)